Platform Technology | Novel Therapies | Advanced Digital Solutions

 LIVE ONLINE 23 September 2021

PharmaTech Integrates Speakers 2021

DAVE TUDOR

Managing Director

Medicines Manufacturing Innovation Centre, CPI

SIR JIM McDONALD

Principal and Vice-Chancellor

University of Strathclyde

JULIETTE WHITE

Vice President, Global SHE & Operations Sustainability

AstraZeneca

IAN REES

Manager for the Inspectorate Strategy and Innovation Unit

MHRA

TAMSIN BERRY

Director

PHP

CLIVE BADMAN OBE FRSE

Executive Director

University of Strathclyde

ROUDIE SHAFIE

Director

OVID Health

KEVIN COOK

Chief Executive Officer

Sterling Pharma Solutions

JON-PAUL SHERLOCK

Head of Innovative Manufacturing Technology

AstraZeneca

DAVID HIPKISS

Chief Executive Officer

Enesi Pharma

LUCY FOLEY

Director of Biologics

CPI

SCOTT LAWSON

Partner

PwC

ROSS MACRAE

Head of Drug Product Manufacturing

Pfizer

JACQUELINE BARRY

Chief Clinical Officer

Cell and Gene Therapy Catapult

ALEX ROBERTSON

Senior Director, Global Clinical Supply Chain

AstraZeneca

ANTHONY DAY

Blockchain Partner, Global Business Services

IBM

SEAN BERMINGHAM

Head of Formulated Products

Process Systems Enterprise

IOANNIS STAVRIDIS

Vice President. Global Sales & Marketing

Siemens Digital Logistics

DAVID PARKINSON

Co-founder and Chief Executive Officer

Brave & Heart

SALVATORE MASCIA

Founder & Chief Executive Officer

CONTINUUS Pharmaceuticals

MATTHEW DUCHARS

Chief Executive Officer

Vaccines Manufacturing & Innovation Centre

ROB INNES

Co-founder and Head of Life Sciences

Wyoming Interactive

MARK TALFORD

Deputy Challenge Director

Medicines Manufacturing

ALASTAIR FLORENCE

Director, CMAC Research Hub 

University of Strathclyde

LEONARDO MAGNESCHI

Head of Molecular Biology

Ingenza

RAJEEV BUDHDEV

Executive Vice President & Head – API R&D

Dr. Reddy’s Laboratories

KATIE MURRAY

Technical Director at MMIC

CPI

MARK PROCTOR CBE

General Manager R&D and Operations

AstraZeneca

MOHAN GANAPATHY

Head of Global Quality and Compliance

Merck & Company, USA

GAVIN REYNOLDS

Principal Scientist, Process Engineering

AstraZeneca

SARAH GOULDING

Challenge Director

UKRI Industrial Strategy Challenge Fund in Medicines Manufacturing

IAN ALLAN

Managing Director

Digital Technologies Group

ALISON NORDON

Reader, Department of Pure and Applied Chemistry

University of Strathclyde

ANDREAS GOTTSCHALK

Business Development Key Technologies Pharma, MODCOS

Glatt

ALASTAIR COUPE

Senior Director, Drug Product Design, Pharmaceutical Sciences

Pfizer Ltd

IAN MUIR

Chief Executive Officer

Porton Biopharma

DAVID SELE

Offering Manager

Atos

CHRIS BALDWIN

Supply Chain Director for Cell & Gene Therapy Products

GSK

JAMES MISKIN

Chief Technical Officer

Oxford BioMedica

FERNANDO MUZZIO

Distinguished Professor of Chemical and Biochemical Engineering

Rutgers University

RUTH HARDY

Director Chemical Research

Pfizer

BARRIE CASSEY

Pharmaceutical and biotechnology technical expert and leader

CPI

AL BOYLE

Chief Technical Operations and Quality Officer

Alnylam Pharmaceuticals

LAURENCE DUPRAS

Head of Supply Chain Technology

GSK Consumer Healthcare

DAVE BERRY

Grand Challenge Lead

Medicines Manufacturing Innovation Centre

JONATHAN HAIGH

Vice President, Process Development

FUJIFILM Diosynth Biotechnologies

JOHN ARTHUR

Director

Medicines Manufacturing Innovation Centre

CHRIS VANN

Chief Operating Officer

Autolus Therapeutics

ALFREDO RAMOS PLASENCIA

Managing Director, Engagement and Ventures

CPI

KWOK PANG

Chief Operating Officer

Autolomous

DAVID LITTLEJOHN

Philips Professor of Analytical Chemistry

University of Strathclyde

MARTIN WARMAN

Associate Member

CPACT

JAMIE UNWIN

Commercial Insight Officer

Nanoform

PAUL DALBY

Co-Director

Future Targeted Healthcare Manufacturing Hub

JOHN MACK

Head of the Perceptive Engineering

Applied Materials

MIKE GIBSON

Chief Technical Officer

Sterling Pharma Solutions

LOUISE WRIGHT

Head of Science for Data Science

National Physical Laboratory (NPL)

BRIAN MULLAN

Head of Innovation, Analytical and Process Development, Cell and Gene Therapies

Yposkesi

ANDREA CUSACK

Chief Executive Officer

leon-nanodrugs

JOHN HARRIS

Life Sciences Advisor

Exonar

TOM OWENS

Solution Consultant

Exonar

ELISABETTE MICELOTTA

Science & Technology Team Leader

Nanoform

AIMEE DOOLE

Strategy, Communications & Marketing Head

Booth Welsh

MARTIN WELSH

Managing Director

Booth Welsh

CHRIS MCCOMB

iTech Managing Director / Booth Welsh Head of Business Development

Booth Welsh

Platform Technology | Novel Therapies | Advanced Digital Solutions

 LIVE ONLINE 23 September 2021